{"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":90}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
    • {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Noto Sans KR","Nanum Barun Gothic"]}
    LOGO
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":50}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US

    • NEWS

    RUDACURE

    NoticeBreaking into the global pharmaceutical market
    		05-23
    Press releasesRudaCure at ARVO 2022
    		05-23
    Academic JournalsInvestigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight
    		05-23
    Press releasesRudaCure to present RCI001 pre-clinical data at ARVO 2022
    		05-23
    Press releasesKIC Washington DC Mass Challenge helping RudaCure enter the US market
    		05-23
    Press releases그 아픔까지 사랑할 거야 (I would even love the pain)
    		05-23
    Academic JournalsComparison of therapeutic effects between topical 8-oxo-2'-deoxyguanosine and corticosteroid in ocul
    		05-23
    IRRudaCure's Participation in 2022 JPM Health Care Conference
    		05-23
    Press releasesDifferences between noteworthy companies in 2021 and K-Bio
    		05-23
    Press releasesRudaCure’s Prof. Kim Dong Hyun, award winner in 2021 Korea Cornea Society’s Film Festival
    		05-23
    CATEGORYTITLEDATE
    Press releases
    Breaking into the global pharmaceutical market
    		2022-05-23
    Press releases
    RudaCure at ARVO 2022
    		2022-05-23
    Academic Journals
    Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight
    		2022-05-23
    Press releases
    RudaCure to present RCI001 pre-clinical data at ARVO 2022
    		2022-05-23
    Press releases
    KIC Washington DC Mass Challenge helping RudaCure enter the US market
    		2022-05-23
    Press releases
    그 아픔까지 사랑할 거야 (I would even love the pain)
    		2022-05-23

    글쓰기

    {"google":["Noto Sans"],"custom":["Nanum Square","Noto Sans KR"]}{"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR"]}

    Company Name  RudaCure Co., Ltd

    CEO  Yong Ho Kim ｜ CPO  Seunghoon Kim
    Location  HQ: R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
    Seoul Office : R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
    US Office : 40W, 37th St. Suite 801 New York, NY 10018
    Corportate registration number  548-86-00995
    COPYRIGHT (C) LOGO. All Rights reserved

    Company Name  RudaCure Co., Ltd ｜ CEO  Yong Ho Kim ｜ CPO  Seunghoon Kim
    Location  
    HQ&Research Institute  R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
    Seoul Office R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
    US Office 40W, 37th St. Suite 801 New York, NY 10018
    Corportate registration number  548-86-00995

    COPYRIGHT (C) RUDACURE. All Rights reserved

    {"google":[],"custom":["Noto Sans KR"]}